Jacobson TA, Ito MK, Maki KC, Orringer CE, Bays HE, Jones PH, et al
You can also compare the broader approach in our Liposomal Delivery guide
For people who struggle with daily medication adherence, the weekly injection may actually be easier to manage despite requiring a needle
About OASIS 4 OASIS 4 was a 64-week phase 3 randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of once-daily oral semaglutide 25 mg versus placebo in 307 adults with obesity (BMI 30 kg/m 2 ) or overweight (BMI 27 kg/m 2 ) with one or more weight-related comorbidities
Effective Weight Loss: Clinical studies show that patients can lose a significant percentage of their body weight with consistent Semaglutide injections
Maximus is exclusively for men